Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Top Story
Prostate Cancer
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
Cedars-Sinai Cancer researchers are developing a microfluidic device with a nanosurface as part of a blood test to inform treatment decisions.
Featured
Financial Results
Roche reports flat diagnostics revenue growth for 2022
Mergers & Acquisitions
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
Latest News
Policy forum reviews NIH response to the COVID-19 pandemic
February 3, 2023
Siemens Healthineers, Unilabs ink 200-million euro agreement
February 2, 2023
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
February 2, 2023
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
February 2, 2023
Business Insights
Financial Results
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
Financial Results
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
Financial Results
Roche reports flat diagnostics revenue growth for 2022
Collaboration
Genetic Technologies, Qiagen forming strategic alliance
Diagnostic Technologies
Collaboration
Siemens Healthineers, Unilabs ink 200-million euro agreement
Pathology and AI
3D spatial maps characterize biology enabling tumor growth: NIH director
Collaboration
Genetic Technologies, Qiagen forming strategic alliance
Artificial Intelligence
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
Diseases
Financial Results
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
Financial Results
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
Sepsis
Sepsis increases heart failure, rehospitalization risks following hospital discharge
Cancer
Study suggests immune response to anticancer checkpoint inhibitors unaffected by COVID-19 vaccination
More from LabPulse.com
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
There were challenges with "vaccine logistics, such as large minimum order sizes for vaccines, requirements for ultra-cold storage, and insufficient ancillary supplies," OIG said.
January 31, 2023
Blood test may predict Alzheimer’s 3.5 years before diagnosis
Researchers have developed a blood-based test that can predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis.
January 30, 2023
University of Missouri researchers say specific long-COVID symptoms fewer than expected
A study shows that people with long COVID were susceptible to developing only seven directly related symptoms from a list of 47 top-reported symptoms.
February 1, 2023
Study: Researchers discover antibodies that recognize all SARS-CoV-2 variants
Some portions of the infamous coronavirus spike remained remarkably unchanged among variants, enabling certain rare antibodies to recognize all SARS-CoV-2 variants.
January 30, 2023
Long-COVID subtypes may help stratify patients, inform treatment strategies: Study
January 27, 2023
Study outlines prevalence of positive COVID-19 test results collected by digital self-report
Researchers evaluated the agreement and deviations between COVID-19 test results obtained via traditional surveillance and self-reported smartphone apps in the U.S. and Germany.
January 31, 2023
Most Popular
Blood test may predict Alzheimer’s 3.5 years before diagnosis
Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
Duke University developing blood test to detect osteoarthritis progression in the knee
More from LabPulse.com
COVID-19 immune response strengthens over time: Study
COVID-19 immunity may gather strength with more time between vaccination and infection; people who’ve had the virus benefit even from delayed vaccination, according to a study published in Journal for Clinical Investigation Insight.
January 27, 2023
Guardant360 CDx breast cancer liquid biopsy test receives FDA approval as companion diagnostic
The Guardant360 CDx blood test uses genomic profiling to identify patients with ESR1 mutations who may benefit from Orserdu therapy.
January 30, 2023
Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients
Researchers have found that carriers of specific hidden bacteria have a 14% chance of developing an antibiotic-resistant infection within 30 days of hospitalization.
January 31, 2023
FDA proposes individual risk assessment for blood donations
Based on updated recommendations, the current donor history questionnaire would be revised to ask prospective donors about new or multiple sexual partners in the past three months.
January 27, 2023
Widespread resistance to last-resort antibiotic spurs development of new assay
Scientists in Germany are developing an assay to detect resistance levels and thereby reduce the frequency of therapeutic failures when using colistin to treat infections with Enterobacter.
January 30, 2023
Cardiovascular disease deaths undergo largest single-year increase since 2015
Age-adjusted mortality rates also increased for the first time in many years, by a substantial 4.6%, indicating a global situation in which people of all ages were impacted by the COVID-19 pandemic, especially before vaccines became available.
January 25, 2023
